Novo Nordisk A/SNVONYSE

Revenue (LTM)

$297.2B

+2.3% YoY

Net Income (LTM)

$98.5B

-2.5% YoY

Free Cash Flow

$29.0B

Revenue CAGR (5Y)

+18.5%

—Marginsstable

FCF$29.0B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	140,800	176,954↑25.7%	232,261↑31.3%	290,403↑25.0%	297,195↑2.3%
Gross Profit	117,142	148,506↑26.8%	196,496↑32.3%	245,881↑25.1%	238,769↓2.9%
Operating Income	58,644	74,809↑27.6%	102,574↑37.1%	128,339↑25.1%	129,834↑1.2%
Net Income	47,757	55,525↑16.3%	83,683↑50.7%	100,988↑20.7%	98,500↓2.5%
EBITDA	65,394	76,802↑17.4%	114,629↑49.3%	137,376↑19.8%	143,937↑4.8%
EPS Diluted	10.37	12.22↑17.8%	18.62↑52.4%	22.63↑21.5%	23.03↑1.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	10,720	12,653↑18.0%	14,392↑13.7%	15,655↑8.8%	26,464↑69.0%
Total Current Assets	85,595	108,194↑26.4%	139,646↑29.1%	160,897↑15.2%	172,453↑7.2%
Total Assets	194,508	241,257↑24.0%	314,486↑30.4%	465,795↑48.1%	542,902↑16.6%
Total Current Liabilities	99,516	120,940↑21.5%	169,655↑40.3%	217,528↑28.2%	215,661↓0.9%
Total Liabilities	123,762	157,771↑27.5%	207,925↑31.8%	322,309↑55.0%	348,855↑8.2%
Total Equity	70,746	83,486↑18.0%	106,561↑27.6%	143,486↑34.7%	194,047↑35.2%
Total Debt	26,645	25,784↓3.2%	27,006↑4.7%	102,787↑280.6%	130,958↑27.4%
Net Debt	15,925	13,131↓17.5%	12,614↓3.9%	87,132↑590.8%	104,494↑19.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	55,000	78,887↑43.4%	108,908↑38.1%	120,968↑11.1%	119,102↓1.5%
Capital Expenditure	-7,385	-14,753↓99.8%	-38,896↓163.6%	-51,309↓31.9%	-90,113↓75.6%
Free Cash Flow	47,615	64,134↑34.7%	70,012↑9.2%	69,659↓0.5%	28,989↓58.4%
Stock-Based Comp	1,040	1,539↑48.0%	2,149↑39.6%	2,289↑6.5%	0
Net Change in Cash	-1,507	1,934↑228.3%	1,739↓10.1%	1,263↓27.4%	10,809↑755.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance